Aptamer Hybrid Nanocomplexes as Targeting Components for Antibiotic/Gene Delivery Systems and Diagnostics: A Review

References

• Stoltenburg R, Reinemann C, Strehlitz B. SELEX—a (r) evolutionary method to generate high-affinity nucleic acid ligands. Biomol Eng. 2007;24(4):381–403. doi:10.1016/j.bioeng.2007.06.00117627883
   PubMedGoogle Scholar
• de Vries JW, Schnichels S, Hurst J, et al. DNA nanoparticles for ophthalmic drug delivery. Biomaterials. 2018;157:98–106. doi:10.1016/j.biomaterials.2017.11.04629258013
   PubMed Web of Science ®Google Scholar
• Rabiee N, Yaraki MT, Garakani SM, et al. Recent advances in porphyrin-based nanocomposites for effective targeted imaging and therapy. Biomaterials. 2019;119707.31874428
   PubMed Web of Science ®Google Scholar
• Bahrami S, Baheiraei N, Mohseni M, et al. Three-dimensional graphene foam as a conductive scaffold for cardiac tissue engineering. J Biomater Appl. 2019;34(1):74–85. doi:10.1177/088532821983903730961432
   PubMed Web of Science ®Google Scholar
• Dollins CM, Nair S, Sullenger BA. Aptamers in immunotherapy. Hum Gene Ther. 2008;19(5):443–450. doi:10.1089/hum.2008.04518473674
   PubMed Web of Science ®Google Scholar
• Levy M, Palliser D, Wengerter BC, Almo SC. Aptamer-Targetted Antigen Delivery. Google Patents; 2017.
   Google Scholar
• Bayraç C, Eyidoğan F, Öktem HA. DNA aptamer-based colorimetric detection platform for Salmonella enteritidis. Biosens Bioelect. 2017;98:22–28. doi:10.1016/j.bios.2017.06.029
   PubMed Web of Science ®Google Scholar
• Hajebi S, Rabiee N, Bagherzadeh M, et al. Stimulus-responsive polymeric nanogels as smart drug delivery systems. Acta Biomater. 2019;92:1–18. doi:10.1016/j.actbio.2019.05.01831096042
   PubMed Web of Science ®Google Scholar
• Ahmadi S, Rabiee N, Rabiee M. Application of aptamer-based hybrid molecules in early diagnosis and treatment of diabetes mellitus: from the concepts towards the future. Curr Diabetes Rev. 2019;15(4):309–313. doi:10.2174/157339981466618060707555029875005
   PubMed Web of Science ®Google Scholar
• Gooch J, Daniel B, Parkin M, Frascione N. Developing aptasensors for forensic analysis. TrAC Trends Anal Chem. 2017;94:150–160. doi:10.1016/j.trac.2017.07.019
   Web of Science ®Google Scholar
• Nussbaum O, Oz MB, Tilayov T, Atiya H, Dagan S. A signal amplification probe enhances sensitivity of antibodies and aptamers based Immuno-diagnostic assays. J Immunol Methods. 2017;448:85–90. doi:10.1016/j.jim.2017.06.00128614699
   PubMed Web of Science ®Google Scholar
• Nour S, Baheiraei N, Imani R, et al. Bioactive materials: a comprehensive review on interactions with biological microenvironment based on the immune response. J Bionic Eng. 2019;16(4):563–581. doi:10.1007/s42235-019-0046-z
   Web of Science ®Google Scholar
• Nour S, Baheiraei N, Imani R, et al. A review of accelerated wound healing approaches: biomaterial-assisted tissue remodeling. J Mater Sci. 2019;30(10):120.
   Web of Science ®Google Scholar
• Bates PJ, Reyes-Reyes EM, Malik MT, Murphy EM, O’toole MG, Trent JO. G-quadruplex oligonucleotide AS1411 as a cancer-targeting agent: uses and mechanisms. Biochimica Et Biophysica Acta (BBA)-General Subj. 2017;1861(5):1414–1428. doi:10.1016/j.bbagen.2016.12.015
   PubMed Web of Science ®Google Scholar
• Howard PT. Investigating the Mechanism of Novel Anticancer Agent, AS1411: Does Metabolism to Guanine Play a Role? 2017.
   Google Scholar
• Feng S, Chen C, Wang W, Que L. An aptamer nanopore-enabled microsensor for detection of theophylline. Biosens Bioelect. 2018;105:36–41. doi:10.1016/j.bios.2018.01.016
   PubMed Web of Science ®Google Scholar
• Pützer BM, Solanki M, Herchenröder O. Advances in cancer stem cell targeting: how to strike the evil at its root. Adv Drug Deliv Rev. 2017;120:89–107. doi:10.1016/j.addr.2017.07.01328736304
   PubMed Web of Science ®Google Scholar
• Tan KX, Danquah MK, Sidhu A, Lau SY, Ongkudon CM. Biophysical characterization of layer‐by‐layer synthesis of aptamer‐drug microparticles for enhanced cell targeting. Biotechnol Prog. 2017.
   Web of Science ®Google Scholar
• Wang Y, Ma T, Ma S, et al. Fluorometric determination of the antibiotic kanamycin by aptamer-induced FRET quenching and recovery between MoS 2 nanosheets and carbon dots. Microchimica Acta. 2017;184(1):203–210. doi:10.1007/s00604-016-2011-4
   Web of Science ®Google Scholar
• Jeong S, Rhee Paeng I. Sensitivity and selectivity on aptamer-based assay: the determination of tetracycline residue in bovine milk. ScientificWorldJournal. 2012;159456(10):1. doi:10.1100/2012/159456
   Google Scholar
• Hori SI, Herrera A, Rossi JJ, Zhou J. Current advances in aptamers for cancer diagnosis and therapy. Cancers. 2018;10:1. doi:10.3390/cancers10010009
   Web of Science ®Google Scholar
• Li F, Wang Q, Zhang H, et al. Characterization of a DNA aptamer for ovarian cancer clinical tissue recognition and in vivo imaging. Cell Physiol Biochem. 2018;51(6):2564–2574. doi:10.1159/00049592530562733
   PubMedGoogle Scholar
• Chen C, Zhou S, Cai Y, Tang F. Nucleic acid aptamer application in diagnosis and therapy of colorectal cancer based on cell-SELEX technology. NPJ Prec Oncol. 2017;1(1):37. doi:10.1038/s41698-017-0041-y
   PubMedGoogle Scholar
• Wu X, Chen J, Wu M, Zhao JX. Aptamers: active targeting ligands for cancer diagnosis and therapy. Theranostics. 2015;5(4):322. doi:10.7150/thno.1025725699094
   PubMed Web of Science ®Google Scholar
• Sun H, Zhu X, Lu PY, Rosato RR, Tan W, Zu Y. Oligonucleotide aptamers: new tools for targeted cancer therapy. Mol Ther Nucl Acids. 2014;3.
   Google Scholar
• Wang Y, Li Z, Hu D, Lin C-T, Li J, Lin Y. Aptamer/graphene oxide nanocomplex for in situ molecular probing in living cells. J Am Chem Soc. 2010;132(27):9274–9276. doi:10.1021/ja103169v20565095
   PubMed Web of Science ®Google Scholar
• Beals N, Thiagarajan PS, Soehnlen E, et al. Five-part pentameric nanocomplex shows improved efficacy of doxorubicin in CD44+ cancer cells. ACS Omega. 2017;2(11):7702–7713. doi:10.1021/acsomega.7b0116830023561
   PubMed Web of Science ®Google Scholar
• Nitsche A, Kurth A, Dunkhorst A, et al. One-step selection of Vaccinia virus-binding DNA aptamers by MonoLEX. BMC Biotechnol. 2007;7(1):48. doi:10.1186/1472-6750-7-4817697378
   PubMedGoogle Scholar
• Darmostuk M, Rimpelova S, Gbelcova H, Ruml T. Current approaches in SELEX: an update to aptamer selection technology. Biotechnol Adv. 2015;33(6):1141–1161. doi:10.1016/j.biotechadv.2015.02.00825708387
   PubMed Web of Science ®Google Scholar
• Han K, Liang Z, Zhou N. Design strategies for aptamer-based biosensors. Sensors. 2010;10(5):4541–4557. doi:10.3390/s10050454122399891
   PubMed Web of Science ®Google Scholar
• Jin B, Wang S, Lin M, et al. Upconversion nanoparticles based FRET aptasensor for rapid and ultrasensitive bacteria detection. Biosens Bioelect. 2017;90:525–533. doi:10.1016/j.bios.2016.10.029
   PubMed Web of Science ®Google Scholar
• Triebenbach AN, Vogl SJ, Leda Lotspeich-Cole DS, Sikes GM, Happ HK. Detection of Francisella tularensis in Alaskan Mosquitoes (Diptera: culicidae) and assessment of a laboratory model for transmission. J Med Entomol. 2010;47(4):639–648. doi:10.1093/jmedent/47.4.63920695280
   PubMed Web of Science ®Google Scholar
• Vivekananda J, Kiel JL. Methods and Compositions for Aptamers Against Anthrax. Google Patents; 2003.
   Google Scholar
• Duan N, Wu S, Chen X, Huang Y, Wang Z. Selection and identification of a DNA aptamer targeted to Vibrio parahemolyticus. J Agric Food Chem. 2012;60(16):4034–4038. doi:10.1021/jf300395z22480209
   PubMed Web of Science ®Google Scholar
• Li P, Yu Q, Zhou L, et al. Probing and characterizing the high specific sequences of ssDNA aptamer against SGIV-infected cells. Virus Res. 2018.
   Web of Science ®Google Scholar
• Kong C, Wang Y, Fodjo EK, Yang G-X, Han F, Shen X-S. Loop-mediated isothermal amplification for visual detection of Vibrio parahaemolyticus using gold nanoparticles. Microchimica Acta. 2018;185(1):35. doi:10.1007/s00604-017-2594-4
   Web of Science ®Google Scholar
• Ramlal S, Mondal B, Lavu PS, Bhavanashri N, Kingston J. Capture and detection of Staphylococcus aureus with dual labeled aptamers to cell surface components. Int J Food Microbiol. 2018;265:74–83. doi:10.1016/j.ijfoodmicro.2017.11.00229132030
   PubMed Web of Science ®Google Scholar
• Liu X, Gao T, Gao X, et al. An aptamer based sulfadimethoxine assay that uses magnetized upconversion nanoparticles. Microchimica Acta. 2017;184(9):3557–3563. doi:10.1007/s00604-017-2378-x
   Web of Science ®Google Scholar
• Luzzago C, Locatelli C, Franco A, et al. Clonal diversity, virulence-associated genes and antimicrobial resistance profile of Staphylococcus aureus isolates from nasal cavities and soft tissue infections in wild ruminants in Italian Alps. Vet Microbiol. 2014;170(1–2):157–161. doi:10.1016/j.vetmic.2014.01.01624565474
   PubMed Web of Science ®Google Scholar
• Wu S, Duan N, Shi Z, Fang C, Wang Z. Simultaneous aptasensor for multiplex pathogenic bacteria detection based on multicolor upconversion nanoparticles labels. Anal Chem. 2014;86(6):3100–3107. doi:10.1021/ac404205c24568625
   PubMed Web of Science ®Google Scholar
• Medley CD, Bamrungsap S, Tan W, Smith JE. Aptamer-conjugated nanoparticles for cancer cell detection. Anal Chem. 2011;83(3):727–734. doi:10.1021/ac102263v21218774
   PubMed Web of Science ®Google Scholar
• Niu W, Teng I-T, Chen X, Tan W, Veige AS. Aptamer-mediated selective delivery of a cytotoxic cationic NHC-Au (I) complex to cancer cells. Dalton Trans. 2018;47(1):120–126. doi:10.1039/C7DT02616A
   Web of Science ®Google Scholar
• Cheng D, Yu M, Fu F, et al. Dual recognition strategy for specific and sensitive detection of bacteria using aptamer-coated magnetic beads and antibiotic-capped gold nanoclusters. Anal Chem. 2015;88(1):820–825. doi:10.1021/acs.analchem.5b0332026641108
   PubMed Web of Science ®Google Scholar
• Charoenphol P, Bermudez H. Aptamer-targeted DNA nanostructures for therapeutic delivery. Mol Pharm. 2014;11(5):1721–1725. doi:10.1021/mp500047b24739136
   PubMed Web of Science ®Google Scholar
• Sun T-M, Du J-Z, Yao Y-D, et al. Simultaneous delivery of siRNA and paclitaxel via a “Two-in-one” micelleplex promotes synergistic tumor suppression. ACS Nano. 2011;5(2):1483–1494. doi:10.1021/nn103349h21204585
   PubMed Web of Science ®Google Scholar
• Farokhzad OC, Jon S, Khademhosseini A, Tran T-NT, LaVan DA, Langer R. Nanoparticle-aptamer bioconjugates: a new approach for targeting prostate cancer cells. Cancer Res. 2004;64(21):7668–7672. doi:10.1158/0008-5472.CAN-04-255015520166
   PubMed Web of Science ®Google Scholar
• Pang X, Cui C, Wan S, et al. Bioapplications of Cell-SELEX-generated aptamers in cancer diagnostics, therapeutics, theranostics and biomarker discovery: a comprehensive review. Cancers. 2018;10(2):47. doi:10.3390/cancers10020047
   PubMed Web of Science ®Google Scholar
• Bamrungsap S, Chen T, Shukoor MI, et al. Pattern recognition of cancer cells using aptamer-conjugated magnetic nanoparticles. ACS Nano. 2012;6(5):3974–3981. doi:10.1021/nn300232822424140
   PubMed Web of Science ®Google Scholar
• Bidard F-C, Fehm T, Ignatiadis M, et al. Clinical application of circulating tumor cells in breast cancer: overview of the current interventional trials. Cancer Metastasis Rev. 2013;32(1–2):179–188. doi:10.1007/s10555-012-9398-023129208
   PubMed Web of Science ®Google Scholar
• DeSantis C, Ma J, Bryan L, Jemal A. Breast cancer statistics, 2013. CA Cancer J Clin. 2014;64(1):52–62. doi:10.3322/caac.2120324114568
   PubMed Web of Science ®Google Scholar
• Riethdorf S, O’Flaherty L, Hille C, Pantel K. Clinical applications of the CellSearch platform in cancer patients. Adv Drug Deliv Rev. 2018;125:102–121. doi:10.1016/j.addr.2018.01.01129355669
   PubMed Web of Science ®Google Scholar
• Jo H, Her J, Ban C. Dual aptamer-functionalized silica nanoparticles for the highly sensitive detection of breast cancer. Biosens Bioelect. 2015;71:129–136. doi:10.1016/j.bios.2015.04.030
   PubMed Web of Science ®Google Scholar
• Mittal S, Kaur H, Gautam N, Mantha AK. Biosensors for breast cancer diagnosis: a review of bioreceptors, biotransducers and signal amplification strategies. Biosens Bioelect. 2017;88:217–231. doi:10.1016/j.bios.2016.08.028
   PubMed Web of Science ®Google Scholar
• Bernaus A, Gaona X, Esbrí JM, Higueras P, Falkenberg G, Valiente M. Microprobe techniques for speciation analysis and geochemical characterization of mine environments: the mercury district of Almadén in Spain. Environ Sci Technol. 2006;40(13):4090–4095. doi:10.1021/es052392l16856721
   PubMed Web of Science ®Google Scholar
• Tanaka Y, Oda S, Yamaguchi H, Kondo Y, Kojima C, Ono A. 15N− 15N J-coupling across HgII: direct observation of HgII-mediated T− T base pairs in a DNA duplex. J Am Chem Soc. 2007;129(2):244–245. doi:10.1021/ja065552h17212382
   PubMed Web of Science ®Google Scholar
• Zhao Y, Xie X. A novel electrochemical aptamer biosensor based on DNAzyme decorated Au@ Ag core-shell nanoparticles for Hg2+ determination. J Braz Chem Soc. 2018;29(2):232–239.
   Web of Science ®Google Scholar
• Tan D, He Y, Xing X, Zhao Y, Tang H, Pang D. Aptamer functionalized gold nanoparticles based fluorescent probe for the detection of mercury (II) ion in aqueous solution. Talanta. 2013;113:26–30. doi:10.1016/j.talanta.2013.03.05523708619
   PubMed Web of Science ®Google Scholar
• Farzin L, Shamsipur M, Sheibani S. A review: aptamer-based analytical strategies using the nanomaterials for environmental and human monitoring of toxic heavy metals. Talanta. 2017;174:619–627. doi:10.1016/j.talanta.2017.06.06628738631
   PubMed Web of Science ®Google Scholar
• Lan L, Yao Y, Ping J, Ying Y. Recent progress in nanomaterial-based optical aptamer assay for the detection of food chemical contaminants. ACS Appl Mater Interfaces. 2017;9(28):23287–23301. doi:10.1021/acsami.7b0393728632380
   PubMed Web of Science ®Google Scholar
• Tian J. Aptamer-based colorimetric detection of various targets based on catalytic Au NPs/Graphene nanohybrids. Sens Bio-Sensing Res. 2019;22:100258. doi:10.1016/j.sbsr.2019.100258
   Google Scholar
• Giorgi-Coll S, Marín MJ, Sule O, Hutchinson PJ, Carpenter KLH. Aptamer-modified gold nanoparticles for rapid aggregation-based detection of inflammation: an optical assay for interleukin-6. Microchimica Acta. 2019;187(1):13. doi:10.1007/s00604-019-3975-731802241
   PubMed Web of Science ®Google Scholar
• Srivastava M, Nirala NR, Srivastava SK, Prakash R. A comparative study of aptasensor vs immunosensor for label-free PSA cancer detection on GQDs-AuNRs modified screen-printed electrodes. Sci Rep. 2018;8(1):1923. doi:10.1038/s41598-018-19733-z29386538
   PubMedGoogle Scholar
• Shen H, Wang J, Liu H, et al. Rapid and selective detection of pathogenic bacteria in bloodstream infections with aptamer-based recognition. ACS Appl Mater Interfaces. 2016;8(30):19371–19378. doi:10.1021/acsami.6b0667127411775
   PubMed Web of Science ®Google Scholar
• Park JY, Jeong HY, Kim MI. Colorimetric detection system for salmonella typhimurium based on peroxidase-like activity of magnetic nanoparticles with DNA aptamers. J Nanomater. 2015;2015.
   Web of Science ®Google Scholar
• Ozyurt C, Bora B, Ugurlu O, Evran S. Chapter 18 - Pathogen-specific nucleic acid aptamers as targeting components of antibiotic and gene delivery systems In: Andronescu E, Grumezescu AM, editors. Nanostructures for Drug Delivery. Elsevier; 2017:551–577.
   Google Scholar
• Lee B, Park J, Ryu M, et al. Antimicrobial peptide-loaded gold nanoparticle-DNA aptamer conjugates as highly effective antibacterial therapeutics against Vibrio vulnificus. Sci Rep. 2017;7(1):13572. doi:10.1038/s41598-017-14127-z29051620
   PubMedGoogle Scholar
• Aslam B, Wang W, Arshad MI, et al. Antibiotic resistance: a rundown of a global crisis. Infect Drug Resist. 2018;11:1645–1658.30349322
   PubMed Web of Science ®Google Scholar
• Zhu C-L, Wang X-W, Lin -Z-Z, Xie Z-H, Wang X-R. Cell microenvironment stimuli-responsive controlled-release delivery systems based on mesoporous silica nanoparticles. J Food Drug Anal. 2014;22(1):18–28. doi:10.1016/j.jfda.2014.01.00224673901
   PubMed Web of Science ®Google Scholar
• Ladju RB, Pascut D, Massi MN, Tiribelli C, Sukowati CH. Aptamer: a potential oligonucleotide nanomedicine in the diagnosis and treatment of hepatocellular carcinoma. Oncotarget. 2018;9(2):2951.29416827
   PubMedGoogle Scholar
• Shigdar S. What potential do aptamers hold in therapeutic delivery? Future Sci. 2017.
   Google Scholar
• Kavruk M, Celikbicak O, Ozalp V, et al. Antibiotic loaded nanocapsules functionalized with aptamer gates for targeted destruction of pathogens. Chem Commun. 2015;51(40):8492–8495. doi:10.1039/C5CC01869B
   PubMed Web of Science ®Google Scholar
• Sancenón F, Yu E, Aznar E, Marcos MD, Martínez-Máñez R. Gated porous materials for biomedical applications. Drug Del Syst. 2017;1:113.
   Google Scholar
• Zhu C-L., Lu C-H., Song X-Y., Yang H-H., Wang X-R.. Bioresponsive controlled release using mesoporous silica nanoparticles capped with aptamer-based molecular gate. J Am Chem Soc. 2011;133(5):1278–1281. doi:10.1021/ja110094g21214180
   PubMed Web of Science ®Google Scholar
• Elsabahy M, Nazarali A, Foldvari M. Non-viral nucleic acid delivery: key challenges and future directions. Curr Drug Deliv. 2011;8(3):235–244. doi:10.2174/15672011179525617421291381
   PubMed Web of Science ®Google Scholar
• Sadeqzadeh E, Rahbarizadeh F, Ahmadvand D, Rasaee MJ, Parhamifar L, Moghimi SM. Combined MUC1-specific nanobody-tagged PEG-polyethylenimine polyplex targeting and transcriptional targeting of tBid transgene for directed killing of MUC1 over-expressing tumour cells. J Controlled Release. 2011;156(1):85–91. doi:10.1016/j.jconrel.2011.06.022
   PubMed Web of Science ®Google Scholar
• Khaleghi S, Rahbarizadeh F, Ahmadvand D, Hosseini HRM. Anti-HER2 VHH targeted magnetoliposome for intelligent magnetic resonance imaging of breast cancer cells. Cell Mol Bioeng. 2017;10(3):263–272.31719864
   PubMed Web of Science ®Google Scholar
• Yin L, Yuvienco C, Montclare JK. Protein based therapeutic delivery agents: contemporary developments and challenges. Biomaterials. 2017;134:91–116. doi:10.1016/j.biomaterials.2017.04.03628458031
   PubMed Web of Science ®Google Scholar
• Lam P, Steinmetz NF. Plant viral and bacteriophage delivery of nucleic acid therapeutics. Wiley Interdiscipl Rev. 2018;10:1.
   Google Scholar
• Pan J, Ruan W, Qin M, et al. Intradermal delivery of STAT3 siRNA to treat melanoma via dissolving microneedles. Sci Rep. 2018;8(1):1117. doi:10.1038/s41598-018-19463-229348670
   PubMedGoogle Scholar
• Li L, Hou J, Liu X, et al. Nucleolin-targeting liposomes guided by aptamer AS1411 for the delivery of siRNA for the treatment of malignant melanomas. Biomaterials. 2014;35(12):3840–3850. doi:10.1016/j.biomaterials.2014.01.01924486214
   PubMed Web of Science ®Google Scholar
• Wu S, Li J, Liang H, et al. Aptamer-based self-assembled supramolecular vesicles for pH-responsive targeted drug delivery. Sci China Chem. 2017;60(5):628–634. doi:10.1007/s11426-016-0351-5
   Web of Science ®Google Scholar
• Bagalkot V, Gao X. siRNA-Aptamer Chimeras on Nanoparticles: Preserving Targeting Functionality for Effective Gene Silencing. ACS Nano. 2011;5(10):8131–8139. doi:10.1021/nn202772p21936502
   PubMed Web of Science ®Google Scholar
• Zintchenko A, Philipp A, Dehshahri A, Wagner E. Simple modifications of branched PEI lead to highly efficient siRNA carriers with low toxicity. Bioconjug Chem. 2008;19(7):1448–1455. doi:10.1021/bc800065f18553894
   PubMed Web of Science ®Google Scholar
• Nimesh S, Aggarwal A, Kumar P, Singh Y, Gupta K, Chandra R. Influence of acyl chain length on transfection mediated by acylated PEI nanoparticles. Int J Pharm. 2007;337(1–2):265–274. doi:10.1016/j.ijpharm.2006.12.03217254724
   PubMedGoogle Scholar
• Mazur J, Roy K, Kanwar JR. Recent advances in nanomedicine and survivin targeting in brain cancers. Nanomedicine. 2018;13(1):105–137. doi:10.2217/nnm-2017-028629161215
   PubMed Web of Science ®Google Scholar
• Urmann K, Modrejewski J, Scheper T, Walter J-G. Aptamer-modified nanomaterials: principles and applications. BioNanoMaterials. 2017;18:1–2.
   Google Scholar
• Kurosaki T, Higuchi N, Kawakami S, et al. Self-assemble gene delivery system for molecular targeting using nucleic acid aptamer. Gene. 2012;491(2):205–209. doi:10.1016/j.gene.2011.09.02122001405
   PubMed Web of Science ®Google Scholar
• Demeneix B, Behr JP. Polyethylenimine (PEI). Adv Genet. 2005;53:215–230.
   Web of Science ®Google Scholar
• Qu J, Yu S, Zheng Y, Zheng Y, Yang H, Zhang J. Aptamer and its applications in neurodegenerative diseases. Cell Mol Life Sci. 2017;74(4):683–695. doi:10.1007/s00018-016-2345-427563707
   PubMed Web of Science ®Google Scholar
• Landi A, Babiuk LA, van Drunen Littel-van den Hurk S. High transfection efficiency, gene expression, and viability of monocyte-derived human dendritic cells after nonviral gene transfer. J Leukoc Biol. 2007;82(4):849–860. doi:10.1189/jlb.090656117626798
   PubMed Web of Science ®Google Scholar
• Shahidi‐Hamedani N, Shier WT, Moghadam Ariaee F, Abnous K, Ramezani M. Targeted gene delivery with noncovalent electrostatic conjugates of sgc‐8c aptamer and polyethylenimine. J Gene Med. 2013;15(6–7):261–269.23794147
   PubMed Web of Science ®Google Scholar
• Askarian S, Abnous K, Ayatollahi S, Farzad SA, Oskuee RK, Ramezani M. PAMAM-pullulan conjugates as targeted gene carriers for liver cell. Carbohydr Polym. 2017;157:929–937. doi:10.1016/j.carbpol.2016.10.03027988010
   PubMed Web of Science ®Google Scholar
• Ozyurt C, Bora B, Ugurlu O, Evran S. Pathogen-specific nucleic acid aptamers as targeting components of antibiotic and gene delivery systems. Nanostruct Drug Del. 2017;551–577.
   Google Scholar
• Cheng J, Teply BA, Sherifi I, et al. Formulation of functionalized PLGA–PEG nanoparticles for in vivo targeted drug delivery. Biomaterials. 2007;28(5):869–876. doi:10.1016/j.biomaterials.2006.09.04717055572
   PubMed Web of Science ®Google Scholar
• Elminger MW, Bell M, Schüett BS, Langkamp M, Kutoh E, Ranke MB. Transactivation of the IGFBP-2 promoter in human tumor cell lines. Mol Cell Endocrinol. 2001;175(1–2):211–218. doi:10.1016/S0303-7207(00)00454-811325531
   PubMed Web of Science ®Google Scholar
• Reslan L, Mestas J-L, Herveau S, Béra J-C, Dumontet C. Transfection of cells in suspension by ultrasound cavitation. J Controlled Release. 2010;142(2):251–258. doi:10.1016/j.jconrel.2009.10.029
   PubMed Web of Science ®Google Scholar
• Emami J, Maghzi P, Hasanzadeh F, Sadeghi H, Mirian M, Rostami M. PLGA-PEG-RA-based polymeric micelles for tumor targeted delivery of irinotecan. Pharm Dev Technol. 2018;23(1):41–54. doi:10.1080/10837450.2017.134095028608760
   PubMed Web of Science ®Google Scholar
• Subramanian N, Kanwar JR, Athalya P, et al. EpCAM aptamer mediated cancer cell specific delivery of EpCAM siRNA using polymeric nanocomplex. J Biomed Sci. 2015;22(1):4. doi:10.1186/s12929-014-0108-925576037
   PubMedGoogle Scholar
• Sarrach S, Huang Y, Niedermeyer S, et al. Spatiotemporal patterning of EpCAM is important for murine embryonic endo-and mesodermal differentiation. Sci Rep. 2018;8(1):1801. doi:10.1038/s41598-018-20131-829379062
   PubMedGoogle Scholar
• Castilla C, Congregado B, Chinchón D, Torrubia FJ, Japón MA, Sáez C. Bcl-xL is overexpressed in hormone-resistant prostate cancer and promotes survival of LNCaP cells via interaction with proapoptotic Bak. Endocrinology. 2006;147(10):4960–4967. doi:10.1210/en.2006-050216794010
   PubMed Web of Science ®Google Scholar
• Beck-Broichsitter M, Merkel OM, Kissel T. Controlled pulmonary drug and gene delivery using polymeric nano-carriers. J Controlled Release. 2012;161(2):214–224. doi:10.1016/j.jconrel.2011.12.004
   PubMed Web of Science ®Google Scholar
• Wang L, Zhou Y, Wu M, et al. Functional nanocarrier for drug and gene delivery via local administration in mucosal tissues. Nanomedicine. 2018;13(1):69–88. doi:10.2217/nnm-2017-014329173025
   PubMed Web of Science ®Google Scholar
• Yamazoe H. Multifunctional protein microparticles for medical applications. Biomaterials. 2018;155:1–12. doi:10.1016/j.biomaterials.2017.10.04529154040
   PubMed Web of Science ®Google Scholar
• Li X, Chen Y, Wang M, Ma Y, Xia W, Gu H. A mesoporous silica nanoparticle–PEI–fusogenic peptide system for siRNA delivery in cancer therapy. Biomaterials. 2013;34(4):1391–1401. doi:10.1016/j.biomaterials.2012.10.07223164421
   PubMed Web of Science ®Google Scholar
• Yin Q, Gao Y, Zhang Z, Zhang P, Li Y. Bioreducible poly (β-amino esters)/shRNA complex nanoparticles for efficient RNA delivery. J Controlled Release. 2011;151(1):35–44. doi:10.1016/j.jconrel.2010.12.014
   PubMed Web of Science ®Google Scholar
• Parhiz H, Hashemi M, Hatefi A, Shier WT, Farzad SA, Ramezani M. Arginine-rich hydrophobic polyethylenimine: potent agent with simple components for nucleic acid delivery. Int J Biol Macromol. 2013;60:18–27. doi:10.1016/j.ijbiomac.2013.05.00123680600
   PubMed Web of Science ®Google Scholar
• Nia AH, Behnam B, Taghavi S, et al. Evaluation of chemical modification effects on DNA plasmid transfection efficiency of single-walled carbon nanotube–succinate–polyethylenimine conjugates as non-viral gene carriers. MedChemComm. 2017;8(2):364–375. doi:10.1039/C6MD00481D30108752
   PubMed Web of Science ®Google Scholar
• Kesharwani P, Gajbhiye V, Jain NK. A review of nanocarriers for the delivery of small interfering RNA. Biomaterials. 2012;33(29):7138–7150. doi:10.1016/j.biomaterials.2012.06.06822796160
   PubMed Web of Science ®Google Scholar
• Moradian H, Fasehee H, Keshvari H, Faghihi S. Poly (ethyleneimine) functionalized carbon nanotubes as efficient nano-vector for transfecting mesenchymal stem cells. Colloids Surf B. 2014;122:115–125. doi:10.1016/j.colsurfb.2014.06.056
   PubMed Web of Science ®Google Scholar
• Mohammadi M, Salmasi Z, Hashemi M, Mosaffa F, Abnous K, Ramezani M. Single-walled carbon nanotubes functionalized with aptamer and piperazine–polyethylenimine derivative for targeted siRNA delivery into breast cancer cells. Int J Pharm. 2015;485(1):50–60. doi:10.1016/j.ijpharm.2015.02.03125712164
   PubMedGoogle Scholar
• Subramanian N, Raghunathan V, Kanwar JR, et al. Target-specific delivery of doxorubicin to retinoblastoma using epithelial cell adhesion molecule aptamer. Mol Vis. 2012;18:2783.23213278
   PubMed Web of Science ®Google Scholar
• Macdonald J, Henri J, Roy K, et al. EpCAM immunotherapy versus specific targeted delivery of drugs. Cancers. 2018;10(1):19. doi:10.3390/cancers10010019
   PubMed Web of Science ®Google Scholar
• Taghavi S, HashemNia A, Mosaffa F, Askarian S, Abnous K, Ramezani M. Preparation and evaluation of polyethylenimine-functionalized carbon nanotubes tagged with 5TR1 aptamer for targeted delivery of Bcl-xL shRNA into breast cancer cells. Colloids Surf B. 2016;140:28–39. doi:10.1016/j.colsurfb.2015.12.021
   PubMed Web of Science ®Google Scholar
• Singh R, Pantarotto D, McCarthy D, et al. Binding and condensation of plasmid DNA onto functionalized carbon nanotubes: toward the construction of nanotube-based gene delivery vectors. J Am Chem Soc. 2005;127(12):4388–4396.15783221
   PubMed Web of Science ®Google Scholar
• Ferreira C, Matthews C, Missailidis S. DNA aptamers that bind to MUC1 tumour marker: design and characterization of MUC1-binding single-stranded DNA aptamers. Tumor Biol. 2006;27(6):289–301. doi:10.1159/000096085
   PubMedGoogle Scholar
• Yang B, Chen B, He M, Yin X, Xu C, Hu B. An aptamer-based dual-functional probe for rapid and specific counting and imaging of MCF-7 cells. Anal Chem. 2018.
   Web of Science ®Google Scholar
• Charbgoo F, Alibolandi M, Taghdisi SM, Abnous K, Soltani F, Ramezani M. MUC1 aptamer-targeted DNA micelles for dual tumor therapy using doxorubicin and KLA peptide. Nanomedicine. 2018;14(3):685–697. doi:10.1016/j.nano.2017.12.01029317345
   PubMed Web of Science ®Google Scholar
• Ebrahimian M, Taghavi S, Mokhtarzadeh A, Ramezani M, Hashemi M. Co-delivery of doxorubicin encapsulated PLGA nanoparticles and Bcl-xL shRNA using alkyl-modified PEI into breast cancer cells. Appl Biochem Biotechnol. 2017;183(1):126–136. doi:10.1007/s12010-017-2434-328236188
   PubMed Web of Science ®Google Scholar
• Afsharzadeh M, Hashemi M, Mokhtarzadeh A, Abnous K, Ramezani M. Recent advances in co-delivery systems based on polymeric nanoparticle for cancer treatment. Artif Cells Nanomed Biotechnol. 2017;1–16.
   Google Scholar
• Zhang RX, Ahmed T, Li LY, Li J, Abbasi AZ, Wu XY. Design of nanocarriers for nanoscale drug delivery to enhance cancer treatment using hybrid polymer and lipid building blocks. Nanoscale. 2017;9(4):1334–1355. doi:10.1039/C6NR08486A27973629
   PubMed Web of Science ®Google Scholar
• Ståhl S, Gräslund T, Karlström AE, Frejd FY, Nygren P-Å, Löfblom J. Affibody molecules in biotechnological and medical applications. Trends Biotechnol. 2017;35(8):691–712. doi:10.1016/j.tibtech.2017.04.00728514998
   PubMed Web of Science ®Google Scholar
• Taghavi S, Nia AH, Abnous K, Ramezani M. Polyethylenimine-functionalized carbon nanotubes tagged with AS1411 aptamer for combination gene and drug delivery into human gastric cancer cells. Int J Pharm. 2017;516(1–2):301–312. doi:10.1016/j.ijpharm.2016.11.02727840158
   PubMedGoogle Scholar
• Tyagi P, Subramony JA. Nanotherapeutics in oral and parenteral drug delivery: key learnings and future outlooks as we think small. J Controlled Release. 2018;272:159–168. doi:10.1016/j.jconrel.2018.01.009
   PubMed Web of Science ®Google Scholar
• Gou Y, Zhang Z, Li D, et al. HSA-based multi-target combination therapy: regulating drugs’ release from HSA and overcoming single drug resistance in a breast cancer model. Drug Deliv. 2018;25(1):321–329. doi:10.1080/10717544.2018.142824529350051
   PubMed Web of Science ®Google Scholar
• D’ANGELO B, Benedetti E, Cimini A, Giordano A. MicroRNAs: a puzzling tool in cancer diagnostics and therapy. Anticancer Res. 2016;36(11):5571–5575. doi:10.21873/anticanres.1114227793880
   PubMed Web of Science ®Google Scholar
• Duan Y, Xing Z, Yang J, et al. Chondroitin sulfate-functionalized polyamidoamine-mediated miR-34a delivery for inhibiting the proliferation and migration of pancreatic cancer. RSC Adv. 2016;6(75):70870–70876. doi:10.1039/C6RA15716E
   Web of Science ®Google Scholar
• Wu D, Wang C, Yang J, et al. Improving the intracellular drug concentration in lung cancer treatment through the codelivery of doxorubicin and miR-519c mediated by porous PLGA microparticle. Mol Pharm. 2016;13(11):3925–3933. doi:10.1021/acs.molpharmaceut.6b0070227684197
   PubMedGoogle Scholar
• Wang Y, Chen J, Liang X, et al. An ATP-responsive codelivery system of doxorubicin and miR-34a to synergistically inhibit cell proliferation and migration. Mol Pharm. 2017;14(7):2323–2332. doi:10.1021/acs.molpharmaceut.7b0018428591517
   PubMed Web of Science ®Google Scholar
• Tang Q, Ma X, Zhang Y, Cai X, Xue W, Ma D. Self-sensibilized polymeric prodrug co-delivering MMP-9 shRNA plasmid for combined treatment of tumors. Acta Biomater. 2018;69:277–289. doi:10.1016/j.actbio.2018.01.01429369806
   PubMed Web of Science ®Google Scholar
• Yang Y, Xie X, Yang Y, et al. Polymer nanoparticles modified with photo-and pH-dual-responsive polypeptides for enhanced and targeted cancer therapy. Mol Pharm. 2016;13(5):1508–1519. doi:10.1021/acs.molpharmaceut.5b0097727043442
   PubMedGoogle Scholar
• Yu S, He C, Lv Q, et al. pH and reduction-sensitive disulfide cross-linked polyurethane micelles for bio-triggered anti-tumor drug delivery. J Controlled Release. 2015;213:e99–e100. doi:10.1016/j.jconrel.2015.05.166
   PubMed Web of Science ®Google Scholar
• Yang S, Ren Z, Chen M, et al. Nucleolin-targeting AS1411-aptamer-modified graft polymeric micelle with Dual pH/redox sensitivity designed to enhance tumor therapy through the codelivery of doxorubicin/TLR4 siRNA and suppression of invasion. Mol Pharm. 2017.
   Google Scholar
• Zhang C, Yang S, Zhu W, et al. Distinctive polymer micelle designed for siRNA delivery and reversal of MDR1 gene‐dependent multidrug resistance. J Biomed Mater Res Part B. 2017;105(7):2093–2106. doi:10.1002/jbm.b.33748
   PubMed Web of Science ®Google Scholar
• Yi Y, Wang H, Wang X, et al. Photocontrollable drug release nanosystem for multifunctional synergistic cancer therapy. acs appl mater interfaces. 2017;9(7):5847–5854. doi:10.1021/acsami.6b1541428124556
   PubMed Web of Science ®Google Scholar
• Liu Z, Sun X, Xiao S, et al. Characterization of aptamer-mediated gene delivery system for liver cancer therapy. Oncotarget. 2017;9:6.
   Google Scholar
• Shahidi-Hamedani N, Shier WT, Moghadam Ariaee F, Abnous K, Ramezani M. Targeted gene delivery with noncovalent electrostatic conjugates of sgc-8c aptamer and polyethylenimine. J Gene Med. 2013;15(6–7):261–269.23794147
   PubMed Web of Science ®Google Scholar
• Wang G-H, Huang G-L, Zhao Y, et al. ATP triggered drug release and DNA co-delivery systems based on ATP responsive aptamers and polyethylenimine complexes. J Mater Chem B. 2016;4(21):3832–3841. doi:10.1039/C5TB02764K32263321
   PubMed Web of Science ®Google Scholar
• Lee J, Oh J, Lee E-S, Kim Y-P, Lee M. Conjugation of prostate cancer-specific aptamers to polyethylene glycol-grafted polyethylenimine for enhanced gene delivery to prostate cancer cells. J Ind Eng Chem. 2019;73:182–191. doi:10.1016/j.jiec.2019.01.023
   Web of Science ®Google Scholar
• Wu D, Zhang Y, Xu X, et al. RGD/TAT-functionalized chitosan-graft-PEI-PEG gene nanovector for sustained delivery of NT-3 for potential application in neural regeneration. Acta Biomater. 2018;72:266–277. doi:10.1016/j.actbio.2018.03.03029578088
   PubMed Web of Science ®Google Scholar